Heart transplant surgery safe and effective: A Canadian retrospective spanning three decades

October 24, 2011 in Cardiology

Heart transplantation is a very safe and effective therapy, according to a new long-term study presented today at the Canadian Cardiovascular Congress 2011, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

Researchers at the University of Ottawa Institute program revealed results from 25 years of follow-up on a total of 461 . Mean age at transplant was 49 ±13 years. Patients were followed and managed according to guidelines in effect at the time.

They found that survival rates have improved by more than 20 per cent over the years since modern became available in 1980.

"Heart transplants are amazingly ," says Dr. Marc Ruel, surgical director of the heart transplant program at the University of Ottawa Heart Institute. "We must remember that half of these patients would otherwise not have lived one year without a transplant."

The Heart Institute found that survival rates have been good over the years, especially from 2003 onward, with more advanced surgical and medical care, where the survival rate at eight years post-surgery is now 89.3 per cent. "Results have significantly improved over the years," says Dr. Ruel.

The study found that overall survival rates for the 25-year period were:

  • At one year – 86%
  • At five years – 75%
  • At 10 years – 62%
  • At 15 years – 47%
  • At 20 years – 36%
Fifty-five per cent of all patients were status 3 or higher – meaning they had more complicated and urgent medical needs – at transplant.

Survival was negatively influenced by age at transplant. The younger the patient is at the time of transplant, the more successful the outcome. Each additional 10 years of age decreases the survival rate by 20 per cent, the study found.

Survival was not significantly affected by gender or by whether a patient was on a ventricular assist device − a mechanical pump that helps a weakened heart pump blood throughout the body − pre-transplant.

Causes of death beyond the perioperative period were cardiac allograft vasculopathy in 36 per cent (at a mean of eight years post-transplant), rejection in six per cent (at a mean 1.4 years post-transplant), sepsis in 10 percent (at a mean of one year post-transplant), cancer in 17 per cent (at a mean of 7.7 years post-transplant), and other causes in 32 per cent (at a mean of 8.2 years post-transplant).

Successful heart transplantation is a team effort that starts with donor identification, consent from families, donor preparation, and collaboration between hospitals. It involves a large team of surgeons, transplant cardiologists, nurses, coordinators, physiotherapists, and social workers.

"Heart transplant is one of the most philosophically, symbolically, surgically and medically beautiful acts," says Dr. Ruel. "Although the number of donors will always be insufficient until we find new therapies such as cardiac regeneration, it is important to recognize the importance of heart transplant programs and of organ donation, in light of the many lives saved and families positively touched by this therapy. We hope that this research conveys the message."

"Heart transplant is a very good choice for some patients," adds Dr. Haissam Haddad, medical director of the University of Ottawa Heart Institute heart transplant program. "It has a strong record of safety and success."

Heart disease is a leading cause of death in Canada. "Heart transplantation is an excellent treatment to the select few who need it," says Heart and Stroke Foundation spokesperson Dr. Beth Abramson. "We can all do our part by signing our donor cards and letting loved ones know our wishes." She also recommends we all lead healthy lives to try to prevent heart disease.

"Canadians with heart failure who otherwise might have died have access to a life-saving procedure thanks to generous donors and our incredible multidisciplinary transplant teams," says Dr. Abramson. "This research is a valuable measure of how this life-saving advance is working for our sickest patients – those who need a new heart."

Heart transplant is used to treat severe, end-stage heart failure. This heart failure may be the result of damage to the heart from coronary artery disease, such as a heart attack; severe, untreated hypertension (hypertensive heart disease); heart valve problems; infections such as viruses; alcohol and illicit drug use; inherited heart disease or congential heart disease.

In 2010 there were 167 heart transplants in Canada, performed in five provinces. On December 31, 2010, there were 135 Canadians on the waiting list for a heart transplant.

Provided by Heart and Stroke Foundation of Canada

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Relevant PhysicsForums posts

More news stories

Costs to treat stroke in America may double by 2030

Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.

Cardiology created 38 minutes ago | popularity not rated yet | comments 0

New blood-thinner measures may cut medication errors

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...

Cardiology created 3 hours ago | popularity not rated yet | comments 0

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

Cardiology created 3 hours ago | popularity not rated yet | comments 0

Study shows low rate of late lumen loss with bioresorbable DESolve device

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...

Cardiology created 3 hours ago | popularity not rated yet | comments 0

Biodegradable stent proves non-inferior to drug-eluting stent

The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...

Cardiology created 19 hours ago | popularity 5 / 5 (1) | comments 0


Scientists uncover molecular roots of cocaine addiction in the brain

Researchers at Johns Hopkins have unraveled the molecular foundations of cocaine's effects on the brain, and identified a compound that blocks cravings for the drug in cocaine-addicted mice. The compound, already proven safe ...

Taming suspect gene reverses schizophrenia-like abnormalities in mice

Scientists have reversed behavioral and brain abnormalities in adult mice that resemble some features of schizophrenia by restoring normal expression to a suspect gene that is over-expressed in humans with ...

Acne treatment: Natural substance-based formula is more effective than artificial compounds

University of Granada scientists have patented a new treatment for acne that is based on completely natural substances and is much more effective than artificial formulas because it does not create resistance ...

Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine

The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...

A molecular explanation for age-related fertility decline in women

(Medical Xpress)—Scientists supported by the National Institutes of Health have a new theory as to why a woman's fertility declines after her mid-30s. They also suggest an approach that might help slow ...

Addiction to unhealthy foods could help explain the global obesity epidemic

Research presented today shows that high-fructose corn syrup can cause behavioural reactions in rats similar to those produced by drugs of abuse such as cocaine. These results, presented by addiction expert Francesco Leri, ...